Switch theme
Sign up to access all valuation multiples
Mauna Kea Technologies SA is a medical device company that develops, manufactures and markets an imaging platform for visualizing tissue at the cellular level, in real time, during standard procedures, with the mission of eliminating uncertainties in diagnosis and treatment through direct visualization of tissue in vivo at the microscopic level. The company’s flagship product, Cellvizio, is the smallest microscope, designed for direct use during minimally invasive procedures. It operates in a single business segment: endomicroscopy. Its geographical presence includes EMEA (Europe, Middle East, Africa), USA and Canada, and Asia with the majority of the revenue deriving from USA and Canada.
2000
65
LTM Revenue $9.0M
Last FY EBITDA -$9.4M
$45.8M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Mauna Kea Technologies has a last 12-month revenue (LTM) of $9.0M and a last 12-month EBITDA of n/a.
In the most recent fiscal year, Mauna Kea Technologies achieved revenue of $9.0M and an EBITDA of -$9.4M.
Mauna Kea Technologies expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Mauna Kea Technologies valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $9.0M | XXX | $9.0M | XXX | XXX | XXX |
| Gross Profit | n/a | XXX | $7.6M | XXX | XXX | XXX |
| Gross Margin | n/a | XXX | 84% | XXX | XXX | XXX |
| EBITDA | n/a | XXX | -$9.4M | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | -104% | XXX | XXX | XXX |
| EBIT | n/a | XXX | -$7.1M | XXX | XXX | XXX |
| EBIT Margin | n/a | XXX | -79% | XXX | XXX | XXX |
| Net Profit | n/a | XXX | -$12.3M | XXX | XXX | XXX |
| Net Margin | n/a | XXX | -136% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $34.0M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of July 17, 2025, Mauna Kea Technologies's stock price is EUR 0 (or $0).
Mauna Kea Technologies has current market cap of EUR 8.9M (or $10.5M), and EV of EUR 38.9M (or $45.8M).
See Mauna Kea Technologies trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $45.8M | $10.5M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of July 17, 2025, Mauna Kea Technologies has market cap of $10.5M and EV of $45.8M.
Mauna Kea Technologies's trades at 5.1x EV/Revenue multiple, and -4.9x EV/EBITDA.
Equity research analysts estimate Mauna Kea Technologies's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Mauna Kea Technologies's P/E ratio is not available.
See valuation multiples for Mauna Kea Technologies and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $10.5M | XXX | $10.5M | XXX | XXX | XXX |
| EV (current) | $45.8M | XXX | $45.8M | XXX | XXX | XXX |
| EV/Revenue | 5.1x | XXX | 5.1x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | -4.9x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | -6.4x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | -0.9x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -6.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialMauna Kea Technologies's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.2M for the same period.
Mauna Kea Technologies's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Mauna Kea Technologies's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Mauna Kea Technologies and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | -104% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 16% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 46% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 163% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Mauna Kea Technologies acquired XXX companies to date.
Last acquisition by Mauna Kea Technologies was XXXXXXXX, XXXXX XXXXX XXXXXX . Mauna Kea Technologies acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Mauna Kea Technologies founded? | Mauna Kea Technologies was founded in 2000. |
| Where is Mauna Kea Technologies headquartered? | Mauna Kea Technologies is headquartered in France. |
| How many employees does Mauna Kea Technologies have? | As of today, Mauna Kea Technologies has 65 employees. |
| Is Mauna Kea Technologies publicy listed? | Yes, Mauna Kea Technologies is a public company listed on PAR. |
| What is the stock symbol of Mauna Kea Technologies? | Mauna Kea Technologies trades under ALMKT ticker. |
| When did Mauna Kea Technologies go public? | Mauna Kea Technologies went public in 2011. |
| Who are competitors of Mauna Kea Technologies? | Similar companies to Mauna Kea Technologies include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Mauna Kea Technologies? | Mauna Kea Technologies's current market cap is $10.5M |
| What is the current revenue of Mauna Kea Technologies? | Mauna Kea Technologies's last 12 months revenue is $9.0M. |
| What is the current EV/Revenue multiple of Mauna Kea Technologies? | Current revenue multiple of Mauna Kea Technologies is 5.1x. |
| Is Mauna Kea Technologies profitable? | Yes, Mauna Kea Technologies is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
